Drugs Made In America Acquisition II Corp. (DMII) stock
DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.23−0.01 (-0.15%)
Close on Nov 18, 2026Market cap $140.15MP/E –Yield –
Drugs Made In America Acquisition II enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Drugs Made In America Acquisition II's enterprise value was $140.56M on Nov 11, 2026.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $140.56M | -8.7% |
| 2025 | Dec 31, 2025 | $153.88M | – |
See a number that looks wrong?